SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001116679-04-002340
Filing Date
2004-11-24
Accepted
2004-11-24 14:02:44
Documents
1

Document Format Files

Seq Description Document Type Size
1 fm144.txt 144 22836
  Complete submission text file 0001116679-04-002340.txt   24741
Mailing Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154
Business Address 345 PARK AVENUE 41ST FLOOR NEW YORK NY 10154 212-750-6700
BIOENVISION INC (Subject) CIK: 0001028205 (see all company filings)

IRS No.: 113375915 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 144 | Act: 33 | File No.: 001-31787 | Film No.: 041166530
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address C/O BIOENVISION INC 509 MADISON AVE SUITE 404 NEW YORK NY 10022 2127506700
LUCI DAVID P (Reporting) CIK: 0001271123 (see all company filings)